MedPath

The Effect of Transcutaneous Electrical Acupoint Stimulation Combined With Transcutaneous Auricular Vagus Nerve Stimulation on Postoperative Delirium in Elderly Patients Undergoing Gastrointestinal Surgery

Not Applicable
Completed
Conditions
Postoperative Delirium
Registration Number
NCT07045090
Lead Sponsor
Affiliated Hospital of Nantong University
Brief Summary

The aim of this clinical trial is to study the effect of transcutaneous electrical acupoint stimulation combined with auricular vagus nerve stimulation on postoperative delirium in elderly patients undergoing gastrointestinal surgery. The study aims to answer the following main questions

1. whether it reduces the expression of inflammatory factors in the acute postoperative period

2. whether it can reduce the incidence of postoperative delirium

Detailed Description

Existing clinical studies have shown that TEAS has demonstrated value in preventing postoperative delirium (POD). Currently, taVNS is commonly used clinically to improve patients' cognitive dysfunction (POCD), and POD is often considered a precursor to the development of POCD. However, no one has yet used the two in combination, so this study aimed to combine the two to investigate their potential benefits in preventing POD.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
116
Inclusion Criteria
  1. Aged ≥65 years;
  2. Body mass index (BMI) 18-30 kg/m²;
  3. American Society of Anesthesiologists (ASA) physical status classification I-III;
  4. Patients scheduled for elective laparoscopic gastrointestinal surgery;
  5. Willingness to provide written informed consent and comply with the treatment regimen;
  6. Absence of severe organic diseases, psychiatric disorders, or preoperative delirium.
Exclusion Criteria
  1. Preoperative Mini-Mental State Examination (MMSE) score <20;
  2. Electrocardiographic evidence of severe bradycardia (heart rate <50 beats per minute);
  3. Presence of skin lesions or infections at the electrical stimulation site;
  4. History of preoperative chemotherapy or radiotherapy;
  5. Concomitant severe organic diseases with compromised tolerance to interventions;
  6. Prior exposure to Transcutaneous Electrical Acupoint Stimulation (TEAS) or transcutaneous auricular vagus nerve stimulation (taVNS) with documented insensitivity;
  7. Inability to communicate normally, dementia, hearing impairment, or severe psychiatric disorders.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Incidence of postoperative deliriumThe first to third days after surgery

Whether delirium occurred after surgery(by 3D-CAM)

Secondary Outcome Measures
NameTimeMethod
IL-6 andTNF-α levelbefore operation(Before anesthesia),the end of the operation(Immediately after the sewing is finished)

the level of IL-6 andTNF-α in the participant's serum(by ELISA)

Time to first postoperative anal defecationPost-operative period until discharge(In about a week)

Time to first postoperative anal defecation

Early activitiesPost-operative period until discharge(in about a week)

The first time to be able to get out of bed and move

VAS pain scoreThe first to third days after surgery

Assessed with a VAS score scale, the highest is 10 and the lowest is 0, the higher the more severe the pain

Adverse eventsThe first to third days after surgery

Nausea and vomiting, sore throat, itching

Trial Locations

Locations (1)

Affiliated Hospital Nantong University

🇨🇳

Nantong, Jiangsu, China

Affiliated Hospital Nantong University
🇨🇳Nantong, Jiangsu, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.